Artemisia annua, an inexpensive alternative to Covid-19 - very promising leads!
Teams of researchers are currently testing the efficacy of Artemisia annua against Covid-19, mainly in the U.S. but also in Europe and South Africa. Several Chinese studies had shown that this plant, traditionally used to treat malaria, had strong antiviral activity against SARS-CoV in 2003.American researchers are enthusiastic: “If subsequent clinical trials are successful, Artemisia annua could potentially be used as a safe, globally available therapy at reasonable cost and offer an alternative to vaccines.”
Research Teams
Columbia University, University of Washington & Worcester Polytechnic
Institute.(Pre-publication
8 January 2021)
UPDATE ON CLINICAL TRIALS
Americas
University of
Kentucky, USA & Max Planck Institute, Germany
“Researchers at the College
of Medicine have launched a clinical trial to test the plant’s efficacy against
COVID-19. A 2005 Chinese study showed that Artemisia annua had
strong antiviral activity against SARS-CoV, the coronavirus responsible for the
SARS epidemic in 2003. Laboratory studies this year indicated that the
leaves of the plant also have strong antiviral activity against SARS-CoV-2, the
virus that causes COVID-19. Although laboratory results are promising, it
is still too early to know whether Artemisia annua can help
treat people with COVID-19. »
https://ukhealthcare.uky.edu/sites/default/files/uk-markey-cancer-center-annual-report-2020-web.pdf (2020 Markey Cancer Center Annual Report)
Columbia
University, University of
Washington & Worcester
Polytechnic Institute, USA
Researchers show in
vitro efficacy of Artemisia annua against SARS-CoV-2. “If
subsequent clinical trials are conclusive, Artemisia annua could
potentially be used as a safe therapy provided worldwide at a reasonable cost
and offer an alternative to vaccines”.https://www.biorxiv.org/content/10.1101/2021.01.08.425825v2 (pre-publication,
8 January 2021)
Instituto
Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico
Launch of a large-scale
clinical study on 360 Covid-19 patients with co-morbidities (diabetes,
obesity, hypertension…) in September 2020. The aim of the clinical trial is to
establish whether Artemisia annua prevents hospitalisation or
serious illness.
Description de l’étude
clinique : https://clinicaltrials.gov/ct2/show/NCT04530617
Mateon
Therapeutics,
California, USA
The laboratory has shown potent in vitro activity
to inhibit the coronavirus that causes Covid-19. It has initiated an in
vivo study to establish the efficacy of artemisinin as an affordable first-line
treatment in India.
Press Releases:
- Mateon expands
its Covid-19 therapeutic program to include artemisinin, April 8th, 2020
- Mateon
Therapeutics to fund observational studies of Artemisinin in developing
countries, July 13th,
2020
- Patient
Enrollment in India, Sept 14th,
2020
University Of
California-Santa Clara, USA
“The team has selected a list of priority
botanicals for deep analysis, focusing on several well-known natural products
that have been used for anti-inflammatory effects or for enhancing the immune
system. The list includes sweet Annie (Artemisia annua, also called
sweet wormwood)”.
Press Release University Of California, 8 July 2020
Europe /
South Africa
Institut Max
Planck & Freie
Universität Berlin (Germany) & University of Copenhagen (Denmark)
« Effective and
affordable treatments for COVID-19 patients are needed. We report on the in
vitro efficacy of Artemisia annua extracts as well as
artemisinin, artesunate and artemether against SARS-CoV-2. The last two are
approved active pharmaceutical ingredients of anti-malarial drugs. (…) Clinical
studies are needed to further evaluate the usefulness of these compounds as
COVID-19 treatment”.
https://www.biorxiv.org/content/10.1101/2020.10.05.326637v1 (pre-publication, 5 October 2020)
North West
University, South Africa
“We are raising funds to scientifically investigate
the potential to develop Artemisia into an effective treatment of COVID-19. All
funds will be managed by North West University”, Prof Frank van der Kooy.
Presentation of research progress
La Maison de
l’Artemisia is a French
humanitarian association promoting the use of Artemisia annua and afra in
the fight against malaria, targeting the most vulnerable populations in the
world. These two plants have been used for centuries in Traditional Medicine in
China and East Africa.Its mission is twofold :
- accelerate research into Artemisia
herbal tea
- oversee and increase its sustainable
production in malaria endemic countries through Houses of Artemisia, local
centres of expertise, which coordinate knowledge and distribution of the
plant.
Contact: Arnaud Nouvion, arnaud@maison-artemisia.org
----------------------
L’Artemisia annua, bienfaits, culture et
utilisations !
132.612 weergaven
10 nov. 2020
24,7K abonnees
En cinq étapes, découvrez dans cette vidéo les semis et repiquages, les récoltes des feuilles et des graines, et, les utilisations et posologies de l’Artémisia, une plante employée — de par sa foultitude de vertus thérapeutiques — depuis la nuit des temps comme médicinale !
De culture aisée, elle pourra prendre sa place dans tous les jardins ! Ainsi, face à la demande très importante, nous avons pris la décision de mettre en place une promotion sur les semences d’Artemisia, et ce, jusqu’à écoulement des stocks !
Cultivons-la, partageons-la et utilisons-la, en toute dissidence fertile !
Les semences : https://kokopelli-semences.fr/fr/p/F1...
Les plants : https://kokopelli-semences.fr/fr/p/F1...
Bon visionnage ! ** www.kokopelli-semences.fr
Chapitres :
0:00 Législations et vertus de la plante
0:47 Faire ses semis d'Artémisia
2:17 Repiquez l'Artémisia
4:29 Faire ses tisanes d'Artémisia
5:46 Récoltez vos semences
d'Artémisia
----------------------------
